Long-term immunogenicity and safety of a non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine : 4-year follow-up of a phase 1 multicentre trial

A multicomponent vaccine has been developed to reduce the frequency of acute exacerbations of COPD associated with non-typeable Haemophilus influenzae (NTHi) and Moraxella catarrhalis (Mcat) infections, containing NTHi (PD and PE-PilA) and Mcat (UspA2) surface proteins. In a randomised, observer-bli...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	De Smedt, Philippe, Leroux-Roels, Geert, Vandermeulen, Corinne, Tasciotti, Annaelisa, Di Maro, Gennaro, Dozot, Marie, Casula, Daniela, Annaratone, Margherita, Riccucci, Daniele, Arora, Ashwani Kumar
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute exacerbation Antibody persistence ANTIGEN CHALLENGES Clinical trial COPD DOMAIN EXACERBATIONS Haemophilus influenzae Medicine and Health Sciences MICROBIOME Moraxella catarrhalis PROTEIN VACCINE STREPTOCOCCUS-PNEUMONIAE SURVIVAL VITRONECTIN
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!